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Summary
The purpose of this study was to determine predictors
of 90-day left ventricular function following acute ST-
segment elevation myocardial infarction (STEMI) using
variables from clinical presentation, biomarker testing,
and cardiovascular magnetic resonance imaging (CMR).
Background
Identifying patients with acute STEMI who experience
adverse remodelling and develop left ventricular dys-
function 3 months post-MI is a priority for guiding sub-
sequent therapy. To our knowledge, this is the first
extensive multi-centre study utilizing CMR assessment
in patients with anterior STEMI.
Methods
Consecutive patients undergoing primary PCI for ante-
rior MI as part of Inhibition of Delta-protein Kinase C
for the Reduction of Infarct Size in Acute Myocardial
Infarction (PROTECTION-AMI) trial, were enrolled
into the CMR sub-study. CMR was performed at base-
line (day 3 to 5) and 3 months and used to evaluate
infarct size (delayed hyperenhancement, DHE), myocar-
dial salvage, microvascular obstruction (MVO), trans-
mural extent of hyper-enhancement, regional and global
left ventricle function. Myocardial oedema imaging was
used to define the area at risk and subsequent calcula-
tion of myocardial salvage index (MSI). Two
independent observers, blinded to functional and clinical
data, performed the myocardial oedema and infarct size
assessment separately. Biochemical markers including
creatine kinase area under the curve (CK AUC), peak
CK and troponin I (Tn I) were collected at specific
time-points.
Results
95 patients were enrolled in the sub-study and 85 com-
pleted the 3 month follow-up, across 24 centres world-
wide. Patients were 63 ± 12 years of age, 77% male and
median time of symptom onset to infusion of drug was
180 ± 90 minutes (q25 111, q50 170, q75 226). Assess-
ment of infarct size and MSI was performed in 81/85
(95%) and 56/85(66%)of patients respectively. Median
LVEF was 56% (45 to 63) at baseline and 60% (49 to 67)
at 3 months (p<0.001). For every increase in one grade
of DHE transmurality, the odds ratio of a segmental
improvement in regional wall motion was almost halved
(0.46, 95% confidence intervals 0.41 - 0.52, p < 0.001).
There was moderate correlation with CK AUC and
infarct size (IS) by CMR at baseline r = (0.66, p <
0.001). IS had moderate inverse correlation with 3
month EF (r = -0.52, p < 0.0001) and was favourable as
compared to MSI (r = -0.39, p < 0.0004) or MVO (r =
- 0 . 3 ,p<0 . 0 0 9 ) .C KA U C ,C Kp e a ka n dT nIp e a ka l l
correlated favourably with LVEF at 3 months (r = -0.52,
-0.53 and -0.56 respectively). In a multivariable model
with biomarker and imaging variables, only baseline
CMR infarct size independently predicted 90-day LVEF.
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This is the first report of a combined CMR protocol
(including myocardial oedema imaging) in a multi-cen-
tre, multi-vendor setting. Although both IS and MSI
were univariate predictors of late functional recovery,
only baseline CMR infarct size independently predicted
90 day left ventricular function. Infarct size using the
late gadolinium technique remains the most robust
CMR tool to predict late LV systolic dysfunction follow-
ing STEMI. Our findings confirm previous studies
showing significant correlations between baseline bio-
chemistry and acute CMR infarct size and between
baseline biochemistry and late LVEF.
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Figure 1 A displays relationship between between infarct size by
CMR with LVEF at 3 months.
Figure 2 displays relationship between CK AUC and infarct size by
CMR at baseline.
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